← Back to headlines
Pfizer's Seagen Integration Analyzed for Oncology Market Impact
An analysis suggests that Pfizer's integration of Seagen is likely to lead to long-term outperformance in the oncology market compared to Amgen, according to financial observers.
14 Jul, 15:51 — 14 Jul, 15:51
Sources
Showing 1 of 1 sources
